Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Long Term Incentive Plan

21 Jan 2019 07:00

RNS Number : 5546N
Obtala Limited
21 January 2019
 

21 January 2019

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

Obtala Limited

("Obtala", the "Group" or the "Company")

(AIM: OBT)

 

Long Term Incentive Plan ("LTIP")

 

Miles Pelham, Chairman, has entered into an LTIP with Paul Dolan, Chief Executive, whereby he has sold 30,000,000 ordinary shares in the Company to Paul Dolan for a consideration of £1,950,000, which remains outstanding free of interest under the terms of a loan agreement under which Mr Dolan has agreed to make payment to Mr Pelham as follows:

(a) £650,000 10 business days after the first trading day after the third anniversary of the agreement;

(b) £650,000 10 business days after the first trading day after the fourth anniversary of the agreement; and

(c) all amounts then remaining under the loan agreement 10 business days after the first trading day after the fifth anniversary of the agreement.

Under the LTIP, Mr Pelham will hold the shares in trust for Mr Dolan, who will acquire beneficial ownership including all voting and dividend rights. Subject to his continued employment by the Company at the end of the relevant period referred to above, upon payment of each tranche of the amount outstanding under the loan agreement, Mr Dolan can request the transfer to him of the pro rata number of shares. Should Mr Dolan leave the Company's employment before the 5th anniversary, Mr Pelham can re-purchase any balance of shares held in trust at the original price, to be satisfied to the extent possible by release of the loan (and any balance in cash), and Mr Dolan must pay all outstanding loan amounts (in respect of any shares which are not re-purchased) within 10 business days of such election.

 

Mr Dolan is entitled to prepay the outstanding loan balance at any time. Mr Dolan may not sell, transfer or give security or grant options over any of the shares purchased until all liabilities under the loan agreement have been discharged.

 

Miles Pelham, Chairman, commented: "I am delighted to have implemented this Long Term Incentive Plan for the benefit of Paul Dolan. As Chief Executive, Paul is critical to the success of Obtala and the creation of value for all our shareholders. As such it is in everyone's interest that I have made these shares available for implementation of the LTIP, which is designed to incentivise Paul and ensure his retention by Obtala for many years to come. It goes without saying that a personal gesture such as this, which protects existing shareholders from dilution, should leave no doubt about my resolve to ensure Obtala is in the best possible shape to increase shareholder value going forwards. I remain as committed as ever to guiding this company to significant scale."

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Miles Christian Pelham

2

Reason for the notification

a)

Position/status

 Chairman

b)

Initial notification/ Amendment

 Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Obtala Limited

b)

LEI

 2138001U7SLCSRKV3P06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

OBT LN

 ISIN GG00B4WJSD17

b)

Nature of the transactions

Sale of 30,000,000 ordinary shares of 1p in Obtala Limited pursuant to the LTIP

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.065

30,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

30,000,000

£1,950,000

e)

Date of the transaction

18 January 2019

f)

Place of the transaction

London

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Paul Dolan

2

Reason for the notification

a)

Position/status

 Chief Executive Officer

b)

Initial notification/ Amendment

 Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Obtala Limited

b)

LEI

 2138001U7SLCSRKV3P06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

OBT LN

 ISIN GG00B4WJSD17

b)

Nature of the transactions

Purchase of 30,000,000 ordinary shares of 1p in Obtala Limited pursuant to the LTIP

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.065

30,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

30,000,000

£1,950,000

e)

Date of the transaction

18 January 2019

f)

Place of the transaction

London

 

 

 

Obtala Limited

Miles Pelham - ChairmanPaul Dolan - CEO

www.obtala.com

+44 (0)20 7099 1940

Arden Partners Plc (Nominated adviser and broker)

Tom PriceMaria Gomez de Olea

+44 (0)20 7614 5900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAKFPFANNEFF
Date   Source Headline
1st Apr 20191:12 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSEquity Raise and Group Restructuring Update
20th Mar 20191:20 pmRNSResults of General Meeting and Change of Name
14th Mar 20195:32 pmRNSHolding(s) in Company
13th Mar 20191:25 pmRNSHolding(s) in Company
11th Mar 20197:00 amRNSHolding(s) in Company
7th Mar 20197:00 amRNSEquity Raise
28th Feb 20197:00 amRNSNotice of General Meeting
21st Jan 20197:01 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSLong Term Incentive Plan
16th Jan 20191:44 pmRNSHolding(s) in Company
14th Jan 20198:08 amRNSQuarterly Update - Replacement
14th Jan 20197:00 amRNSQuarterly Update
11th Jan 20197:00 amRNSAppointment of New Nominated Adviser and Broker
10th Jan 20197:00 amRNSGroup Reorganisation and Fundraising
21st Nov 201812:49 pmRNSUpdate re: Nominated Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
2nd Nov 20183:19 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:14 pmRNSTotal Voting Rights
2nd Nov 20187:00 amRNSDirector/PDMR Shareholding
1st Nov 201811:43 amRNSNominated Adviser Status
1st Nov 20187:00 amRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20184:02 pmRNSDirector/PDMR Shareholding
30th Oct 201810:01 amRNSFunding Closed
30th Oct 20188:01 amRNSCapital raise, board, name change,strategic update
22nd Oct 201810:19 amRNSHolding(s) in Company
2nd Oct 20187:00 amRNSQuarterly update
14th Sep 20181:12 pmRNSDirector/PDMR Shareholding
14th Sep 20189:30 amRNSDirector/PDMR Shareholding
13th Sep 201810:37 amRNSDirector/PDMR Shareholding
13th Sep 20189:32 amRNSDirector/PDMR Shareholding
12th Sep 20189:13 amRNSDirector/PDMR Shareholding
11th Sep 20182:57 pmRNSDirector/PDMR Shareholding
11th Sep 201811:01 amRNSDirector/PDMR Shareholding
10th Sep 20181:52 pmRNSDirector/PDMR Shareholding
5th Sep 201811:02 amRNSDirector/PDMR Shareholding
4th Sep 20183:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20184:43 pmRNSHalf-year Report
29th Aug 20189:21 amRNSHolding(s) in Company
26th Jul 20184:10 pmRNSDirector/PDMR Shareholding
23rd Jul 201811:32 amRNSDirector/PDMR Shareholding
23rd Jul 201810:27 amRNSDirector/PDMR Shareholding
23rd Jul 201810:08 amRNSHolding(s) in Company
18th Jul 20185:05 pmRNSHolding(s) in Company
16th Jul 20189:19 amRNSDirector/PDMR Shareholding Amendment
13th Jul 20182:36 pmRNSHolding(s) in Company
13th Jul 20182:09 pmRNSDirector/PDMR Shareholding
11th Jul 201810:12 amRNSDirector/PDMR Shareholding
9th Jul 20182:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.